MEDISIEVE
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuously circulated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specif... ically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body. MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.
MEDISIEVE
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.medisieve.com
Total Employee:
11+
Status:
Active
Total Funding:
10.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Euro Google Maps
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
UK Research and Innovation
UK Research and Innovation investment in Grant - MediSieve
24 Haymarket
24 Haymarket investment in Venture Round - MediSieve
Innovate UK
Innovate UK investment in Grant - MediSieve
SBRI Healthcare
SBRI Healthcare investment in Grant - MediSieve
Biomedical Catalyst Fund
Biomedical Catalyst Fund investment in Grant - MediSieve
Wharton Asset Management Company Limited
Wharton Asset Management Company Limited investment in Series A - MediSieve
24 Haymarket
24 Haymarket investment in Series A - MediSieve
National Institute of Health Research
National Institute of Health Research investment in Grant - MediSieve
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - MediSieve
MassChallenge
MassChallenge investment in Grant - MediSieve
Newest Events participated
Participated in Angels in MedCity Pitching Event Apr-2017
on 2017-04-26 as exhibitor
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
Official Site Inspections
http://www.medisieve.com
- Host name: a0b1d980e1f2226c6.awsglobalaccelerator.com
- IP address: 52.223.52.2
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "MediSieve"
Medisieve
At MediSieve, we use nanoengineered magnetic particles to game-change blood filtration, enabling unprecedented levels of selectivity and efficacy, thus revolutionising the treatment …See details»
MediSieve - Crunchbase Company Profile & Funding
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a …See details»
Team - Medisieve
The people behind MediSieve. Building a Better Tomorrow: get to know the exceptional team behind our innovation. Join the team. Our Management Team. Dr George Frodsham. Founder …See details»
MediSieve Company Profile 2024: Valuation, Funding & Investors
Operator of a biotechnology company intended to develop magnetic blood filtration devices for treating blood-borne diseases.See details»
MediSieve Company Profile - Office Locations, Competitors, …
MediSieve is a medical device company developing and commercializing a therapeutic platform for the treatment of blood-borne diseases. Its technology can selectively remove harmful …See details»
George Frodsham - changemakers.rsc.org
George Frodsham is the CEO and founder of MediSieve, a London based biotech that has developed a platform technology that enables the specific removal of harmful substances from …See details»
MediSieve - VentureRadar
We are a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in …See details»
MediSieve - Products, Competitors, Financials, Employees, …
MediSieve is a biotechnology company focused on developing a platform therapy known as Magnetic Haemofiltration for the healthcare sector. Use the CB Insights Platform to explore …See details»
MediSieve - Company Profile - Tracxn
2 days ago · Developer of magnetic therapy to treat blood-borne diseases. The company has developed a magnetic blood filtration solution to identify and remove infected cells, pathogens, …See details»
George Frodsham - Founder & CEO @ MediSieve - Crunchbase
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter. …See details»
Company of the Month - MediSieve - MedCity
Jul 29, 2020 · In February 2019 we featured MediSieve as our Company of the Month. The company, which has developed a unique blood filtration device to treat sepsis and malaria, had undergone a rapid phase of growth.See details»
Medisieve - News
MediSieve has recently shared its mission and latest research developments with leading media agencies. Dr Cristina Blanco-Andujar shared her thoughts on the importance of gender …See details»
MediSieve to Speak at ACCESS CHINA Partnering Forum
September 23rd, 2024 (Shanghai) — We are glad to announce that Dr. George Frodsham, the Founder & Chief Executive Officer of MediSieve, will be presenting at the ACCESS CHINA …See details»
Chris Jones - Non Executive Director and Special Advisor at …
Chris currently serves as the Executive Chairman of Global Access Dx (GADx) and Chairman of FREEHAND - OR Productivity Ltd. Chris is also the Non-Executive Director and Special …See details»
Medisieve - News
MediSieve, the company behind a revolutionary magnetic sieve that filters out malaria-infected cells directly from a patient’s bloodstream, is developing new methods to fight leukaemia.See details»
Chemistry against COVID: MediSieve tackling the virus inside and …
May 6, 2020 · Meet MediSieve, helping isolate COVID-related elements in blood and 3D printing to protect medics’ ears #ChemVsCOVID.See details»
Medisieve - Technology
Many substances in the blood cause serious clinical problems or prevent existing therapies from being effective. Until now, there was no solution that enabled the specific depletion of such …See details»
MediSieve is growing: from an idea to steady growth. - YouTube
Mar 3, 2020 · Over the year MediSieve has gone through a series of exciting changes. George Frodsham (CEO) and Cristina Blanco Andujar (CTO) talk about our research progre...See details»
News - Medisieve
MediSieve, the company behind a revolutionary magnetic sieve that filters out malaria-infected cells directly from a patient’s bloodstream, is developing new methods to fight leukaemia.See details»
Medisieve - Pipeline
MediSieve's product offers a unique selling point by providing the ability to modulate the IL-6 cascade through the physical removal of soluble IL-6 from the blood. This innovative …See details»